MedPath

Comparison the effect of Letrozole with Misoprostol on induction of first trimester abortion in pregnancy

Phase 2
Conditions
Therapeutic Abortion.
Therapeutic/Medical Abortion (termination of pregnancy)
Registration Number
IRCT2015050119037N8
Lead Sponsor
Investigator
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
70
Inclusion Criteria

Pregnant women with 18 to 34 years of age with nonviable pregnancy under 12 weeks from the first day of last menstrual period.
Exclusion criteria:
History of systemic diseases or presence of acute conditions that require any urgent intervention and treatment.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The interval between induction and abortion beginning and opening of cervical internal os. Timepoint: Until 24 hours after receiving Misoprostol, every 1 hour. Method of measurement: Physical examination.;The interval between induction and complete abortion. Timepoint: Until 24 hours after receiving Misoprostol, every 1 hour. Method of measurement: Sonography.
Secondary Outcome Measures
NameTimeMethod
Gastrointestinal problems (nausea or vomiting). Timepoint: From receiving Letrozole until 24 hours after receiving Misoprostol. Method of measurement: Objective.
© Copyright 2025. All Rights Reserved by MedPath